Activation of the phosphatidylinositol-3-kinase (PI3-K)/protein kinase B (AKT) pathway is associated with three major radioresistance mechanisms: intrinsic radioresistance; tumour-cell proliferation; and hypoxia. Monitoring and manipulation of this signal-transduction pathway can have important implications for the management of head and neck cancer, because activation of the PI3-K/AKT pathway is a frequent event in these tumours. PI3-K/AKT signalling regulates cellular processes, including proliferation, invasion, apoptosis, and the upregulation of hypoxia-related proteins. Activation of this pathway can be caused by stimulation of receptor tyrosine kinases, such as epidermal growth factor receptor (EGFR). In clinical trials, a strong and independent association has been noted between expression of activated AKT and treatment outcome. Therefore, the search for molecular predictors of sensitivity to EGFR-directed treatment should be extended to markers of PI3-K/AKT activation. Another strategy might be the direct targeting and inhibition of this pathway. Such inhibition will enhance the efficacy of radiotherapy, by antagonising radiation-induced cellular defense mechanisms, especially in tumours that have activated the PI3-K/AKT cascade. Thus, the activation status of this pathway might be a key element for the prediction of treatment response and for therapeutic targeting in head and neck cancer.

• MeSH
• aktivace enzymů účinky záření   MeSH
• fosfatidylinositol-3-kinasy metabolismus   účinky záření   MeSH
• hypoxie buňky účinky záření   MeSH
• inhibitory fosfoinositid-3-kinasy MeSH
• lidé MeSH
• nádory hlavy a krku enzymologie   radioterapie   MeSH
• prognóza MeSH
• protoonkogenní proteiny c-akt antagonisté a inhibitory   metabolismus   účinky záření   MeSH
• signální transdukce fyziologie   účinky záření   MeSH
• spinocelulární karcinom enzymologie   radioterapie   MeSH
• Check Tag
• lidé MeSH